Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Brain Neoplasms × Letrozole × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 45 Endometrial Neoplasms 10 Triple Negative Breast Neoplasms 3 Ovarian Neoplasms 3 Neoplasms 3 Fallopian Tube Neoplasms 3 Progesterone Resistance 2 Polycystic Ovary Syndrome 2 HR Positive HER2 Negative Advanced Breast Cancer 2 Endometrial Hyperplasia 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Neoplasms, Male 2 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Pathologic Complete Response 1 Obesity 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Low-Grade Serous Ovarian Cancer 1 Low Grade Serous Ovarian Carcinoma 1 Low Grade Serous Ovarian Cancer 1 Locoregional Recurrence 1 Leiomyoma 1 Infertility, Female 1

Interventions

Radiosurgery 23 Magnetic Resonance Spectroscopy 21 Temozolomide 13 Bevacizumab 11 pembrolizumab 10 Specimen Handling 9 Radiotherapy 7 Nivolumab 7 Ipilimumab 7 Magnetic Resonance Imaging 6 Mental Status and Dementia Tests 5 Cyclophosphamide 5 Capecitabine 5 Blood Specimen Collection 5 encorafenib 4 Radiation 4 Neuropsychological Tests 4 Memantine 4 Carboplatin 4 fludarabine 3 fluciclovine F-18 3 binimetinib 3 abemaciclib 3 Proton Therapy 3 Etoposide 3 Dexamethasone 3 Adrenal Cortex Hormones 3 trastuzumab deruxtecan 2 sacituzumab govitecan 2 osimertinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03122197 2026-04-16

Study of Letrozole in Recurrent Gliomas

University of Cincinnati

Phase EARLY_PHASE1 Recruiting

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡